Last reviewed · How we verify
NCT05155813
Prevalence of Sleep Apnea and Atrial Fibrillation
trial testing WatchPAT in Sleep Apnea in 300 participants. Status unknown.
31 December 2023
Quick facts
| Lead sponsor | Brigham and Women's Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 1 February 2022 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- WatchPAT
Conditions studied
- Sleep Apnea — all drugs for Sleep Apnea →
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
Sponsor
Brigham and Women's Hospital
Who can join
18 and older, any sex, with Sleep Apnea or Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators will screen consecutive patients presenting to the atrial fibrillation clinic for sleep apnea using a FDA-approved home sleep testing device, WatchPAT to determine prevalence of sleep apnea in a clinic-based sample.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Evaluation of obstructive sleep apnea among consecutive patients with all patterns of atrial fibrillation using WatchPAT home sleep testing.
Mills EW, Cassidy M, Sofer T, Tadros T, et al · · 2023 · cited 8× · PMID 37019195 · DOI 10.1016/j.ahj.2023.03.014
Verify or expand the search:
- PubMed search for NCT05155813
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of WatchPAT
Trials testing the same drug.
- NCT05042154 — Prevalence of OSA in COPD and the Clinical Impact of OSA Diagnosis and Treatment · NA · unknown
Other recruiting trials for Sleep Apnea
Currently open trials in the same condition.
- NCT07086742 — Validation of the Smart Mask V1 System and Its Measurements of SpO2 and Pulse Rate · NA · recruiting
- NCT07243405 — Neurostimulation for Sleep Disordered Breathing (SDB) · NA · recruiting
- NCT06931028 — A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI≥28 kg/m2 · Phase 3 · recruiting
- NCT06649929 — Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Coup · Phase 2 · recruiting
- NCT06755840 — Sleep Disordered Breathing and Multimorbidity: The Xiangya SDB Cohort Study · recruiting
Other Brigham and Women's Hospital trials
Trials by the same sponsor.
- NCT07011758 — Dynamic Treatment Regimes for Opioid Use Disorder · Phase 2 · not yet recruiting
- NCT06310018 — Augmented Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for PE · suspended
- NCT04519177 — Randomized Trial of a Sleep Disorders Program on Firefighter Safety and Disability ... · NA · not yet recruiting
- NCT06355986 — Computerized Decision Support to Prevent Stroke in Atrial Fibrillation · NA · not yet recruiting
- NCT06099275 — Evaluation of Hemodynamics in People With Untreated Preeclampsia Using Echocardiography · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05155813 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Brigham and Women's Hospital
- Last refreshed: 7 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05155813.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing